West Pharmaceutical Services Amortization remained flat by 0.0% to $600.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from $900.00K to $600.00K. Over 4 years (FY 2021 to FY 2025), Amortization shows a downward trend with a -15.1% CAGR.
Higher amortization often signals significant past M&A activity or heavy investment in intellectual property, whereas lower levels suggest fewer intangible assets being written off.
This represents the non-cash charge associated with the write-down of intangible assets, such as patents, software, or a...
Standard for technology companies with significant intellectual property portfolios; peers often report this separately from tangible depreciation.
operating_adjustment_for_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.10M | $1.10M | $2.10M | $900.00K | $900.00K | $900.00K | $1.00M | $900.00K | $500.00K | $900.00K | $1.30M | $900.00K | $900.00K | $900.00K | $900.00K | $900.00K | $600.00K | $700.00K | $600.00K | $600.00K |
| QoQ Change | — | +0.0% | +90.9% | -57.1% | +0.0% | +0.0% | +11.1% | -10.0% | -44.4% | +80.0% | +44.4% | -30.8% | +0.0% | +0.0% | +0.0% | +0.0% | -33.3% | +16.7% | -14.3% | +0.0% |
| YoY Change | — | — | — | — | -18.2% | -18.2% | -52.4% | +0.0% | -44.4% | +0.0% | +30.0% | +0.0% | +80.0% | +0.0% | -30.8% | +0.0% | -33.3% | -22.2% | -33.3% | -33.3% |